249 related articles for article (PubMed ID: 35189369)
1. Nucleosides and emerging viruses: A new story.
Roy V; Agrofoglio LA
Drug Discov Today; 2022 Jul; 27(7):1945-1953. PubMed ID: 35189369
[TBL] [Abstract][Full Text] [Related]
2. A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase.
Khan S; Attar F; Bloukh SH; Sharifi M; Nabi F; Bai Q; Khan RH; Falahati M
Int J Biol Macromol; 2021 Jun; 181():605-611. PubMed ID: 33766591
[TBL] [Abstract][Full Text] [Related]
3. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target.
Wang Y; Anirudhan V; Du R; Cui Q; Rong L
J Med Virol; 2021 Jan; 93(1):300-310. PubMed ID: 32633831
[TBL] [Abstract][Full Text] [Related]
4. Biostructural Models for the Binding of Nucleoside Analogs to SARS-CoV-2 RNA-Dependent RNA Polymerase.
Prussia AJ; Chennamadhavuni S
J Chem Inf Model; 2021 Mar; 61(3):1402-1411. PubMed ID: 33655751
[TBL] [Abstract][Full Text] [Related]
5. Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
Geraghty RJ; Aliota MT; Bonnac LF
Viruses; 2021 Apr; 13(4):. PubMed ID: 33924302
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside analog inhibitors of hepatitis C virus replication.
Carroll SS; Olsen DB
Infect Disord Drug Targets; 2006 Mar; 6(1):17-29. PubMed ID: 16787301
[TBL] [Abstract][Full Text] [Related]
7. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
8. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs.
Maheden K; Todd B; Gordon CJ; Tchesnokov EP; Götte M
Enzymes; 2021; 49():315-354. PubMed ID: 34696837
[TBL] [Abstract][Full Text] [Related]
10. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.
Picarazzi F; Vicenti I; Saladini F; Zazzi M; Mori M
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287144
[TBL] [Abstract][Full Text] [Related]
11. A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19.
Jockusch S; Tao C; Li X; Anderson TK; Chien M; Kumar S; Russo JJ; Kirchdoerfer RN; Ju J
Antiviral Res; 2020 Aug; 180():104857. PubMed ID: 32562705
[TBL] [Abstract][Full Text] [Related]
12. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
Front Immunol; 2022; 13():844749. PubMed ID: 35464436
[TBL] [Abstract][Full Text] [Related]
13. 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses.
Uemura K; Nobori H; Sato A; Toba S; Kusakabe S; Sasaki M; Tabata K; Matsuno K; Maeda N; Ito S; Tanaka M; Anraku Y; Kita S; Ishii M; Kanamitsu K; Orba Y; Matsuura Y; Hall WW; Sawa H; Kida H; Matsuda A; Maenaka K
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2304139120. PubMed ID: 37831739
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic Test of Benzo[4,5]imidazo[1,2-c]pyrimidinone-Based Nucleoside and Non-Nucleoside Derivatives against DNA and RNA Viruses, Including Coronaviruses.
Kamzeeva P; Petushkov I; Knizhnik E; Snoeck R; Khodarovich Y; Ryabukhina E; Alferova V; Eshtukov-Shcheglov A; Belyaev E; Svetlova J; Vedekhina T; Kulbachinskiy A; Varizhuk A; Andrei G; Aralov A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834006
[TBL] [Abstract][Full Text] [Related]
15. The future of antivirals: broad-spectrum inhibitors.
Debing Y; Neyts J; Delang L
Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
[TBL] [Abstract][Full Text] [Related]
16. Nucleosides for the treatment of respiratory RNA virus infections.
Jordan PC; Stevens SK; Deval J
Antivir Chem Chemother; 2018; 26():2040206618764483. PubMed ID: 29562753
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside analogues for the treatment of coronavirus infections.
Pruijssers AJ; Denison MR
Curr Opin Virol; 2019 Apr; 35():57-62. PubMed ID: 31125806
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
Agostini ML; Andres EL; Sims AC; Graham RL; Sheahan TP; Lu X; Smith EC; Case JB; Feng JY; Jordan R; Ray AS; Cihlar T; Siegel D; Mackman RL; Clarke MO; Baric RS; Denison MR
mBio; 2018 Mar; 9(2):. PubMed ID: 29511076
[TBL] [Abstract][Full Text] [Related]
19. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
[TBL] [Abstract][Full Text] [Related]
20. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections.
Jin YH; Min JS; Jeon S; Lee J; Kim S; Park T; Park D; Jang MS; Park CM; Song JH; Kim HR; Kwon S
Phytomedicine; 2021 Jun; 86():153440. PubMed ID: 33376043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
